Acute myelitis and Lyme disease;Myélite aiguë et neuroborréliose

Revue Neurologique

Volumn 163, Issue 11, 2007, Pages 1039-1047

  Blanc, F ^a   Froelich, S ^a   Vuillemet, F ^b   Carre S ^c   Baldauf, E ^b   De Martino, S ^a   Jaulhac, B ^a   Maitrot, D ^a   Tranchant, C ^a   De Seze, J ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Hôpitaux Civils de Colmar   (France)

^c Centre Hospitalier de Haguenau   (France)

Author keywords

Acute myelitis; Intrathecal anti Borrelia antibody index; Lyme disease; Neuroborreliosis; Spinal MRI

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIBODY; CEFTRIAXONE; METHYLPREDNISOLONE; NETILMICIN;

ADULT; AGED; ARTICLE; BORRELIA; CEREBROSPINAL FLUID; COHORT ANALYSIS; DISEASE COURSE; FACIAL NERVE PARALYSIS; FEMALE; HEADACHE; HUMAN; LYME DISEASE; MALE; MYELITIS; NEUROBORRELIOSIS; NONHUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; SEROLOGY; SPINAL CORD; SUBARACHNOID HEMORRHAGE;

EID: 37149019629     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)74176-0     Document Type: Article

References (25)

1. BAI Y, NARAYAN K, DAIL D et al. (2004). Spinal cord involvement in the nonhuman primate model of Lyme disease. Lab Invest, 84: 160-172.
2. BLANC F, JAULHAC B, FLEURY M et al. (2007). Relevance of the anti-Borrelia antibody index to diagnose neuroborreliosis among seropositive patients. Neurology, sous presse.
3. CDC. (1997). Case definitions for infectious conditions under public health surveillance. Morb Mortal wkly Rep, 46: 1-55.
4. CEPOK S, ZHOU D, VOGEL F, ROSCHE B, GRUMMEL V, SOMMER N et al. (2003). The immune reponse at onset and during recovery from Borrelia burgdorferi meningoradiculitis. Arch Neurol, 60: 849-855.
5. DE SEZE J, STOJKOVIC T, BRETEAU G et al. (2001). Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain, 124: 1509-1521.
6. DRYDEN MS, O'CONNEL S, SAMUEL W, IANNOTTI F. (1996). Lyme myelitis mimicking neurological malignancy. Lancet, 348: 624.
7. GARIN, C, BUJADOUX C. (1922). Paralysie par les tiques. J Med Lyon, 71: 765-767.
8. HANSEN K, LEBECH AM. (1992). The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain, 115: 399-423.
9. HUISMAN TA, WOHLRAB G, NADAL D, BOLTSHAUSER E, MARTIN E. (1999). Unusual presentations of neuroborreliosis (Lyme disease) in childhood. J Comput Assist Tomogr, 23: 39-42.
10. KAISER R, LUCKING CH. (1993). Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci, 118: 64-72.
11. KOHLER J. (1989). Lyme borreliosis: a case of transverse myelitis with syrinx cavity. Neurology, 39: 1553-1554.
12. KRUGER H, REUSS K, PULZ M et al. (1989). Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. J Neurol, 236: 322-328.
13. LESCA G, DESCHAMPS R, LUBETZKI C, LEVY R, ASSOUS M. (2002). Acute myelitis in early Borrelia burgdorferi infection. J Neurol, 249: 1472-1474.
14. LINSSEN WH, GABREELS FJ, WEVERS RA. (1991). Infective acute transverse myelopathy. Report of two cases. Neuropediatrics, 22: 107-109.
15. MACKWORTH-YOUNG CG, HARRIS EN, STEERE AC et al. (1988). Anti-cardiolipin antibodies in Lyme disease. Arthritis Rheum, 31: 1052-1056.
16. MANTIENNE C, ALBUCHER JF, CATALAA I, SEVELY A, COGNARD C, MANELFE C. (2001). MRI in Lyme disease of the spinal cord. Neuroradiology, 43: 485-488.
17. MEURS L, LABEYE D, DECLERCQ I, PIERET F, GILLE M. (2004). Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur Neurol, 52: 186-188.
18. OKSI J, KALIMO H, MARTTILA RJ, MARJAMAKI M et al. (1996). Inflammatory brain changes in Lyme borreliosis. Brain, 119: 2143-2154.
19. OLIVARES JP, PALLAS F, CECCALDI M, VITON JM, RAOULT D, PLANCHE D et al. (1995). Lyme disease presenting as isolated acute urinary retention caused by transverse myelitis: an electrophysiological and urodynamical study. Arch Phys Med Rehabil, 76: 1171-1172.
20. OSCHMANN P, DORNDORF W, HORNIG C, SCHÄFER C, WELLENSIEK HJ, PFLUGHAUPT KW. (1998). Stages and syndromes of neuroborreliosis. J Neurol, 245: 262-272.
21. RAMIREZ C, DE SEZE J, DELALANDE S et al. (2004). Myélopathies infectieuses : profiles cliniques, paracliniques et évolutifs. Rev Neurol, 160 : 1048-1058.
22. REIBER H, LANGE P. (1991). Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem, 37: 1153-1160.
23. ROUSSEAU JJ, LUST C, ZANGERLE PF, BIGAIGNON G. (1986). Acute transverse myelitis as presenting neurological feature of Lyme disease. Lancet, 2: 1222-1223.
24. SCHEID R, HUND-GEORGIADIS M, VON CRAMON DY. (2003). Intracerebral haemorrhage as a manifestation of Lyme Neuroborreliosis. Eur J Neurol, 10: 99-101.
25. STANEK G, O'CONNELL S, CIMMINO M et al. (1996). European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr, 108: 741-747.